Patent owners have been shocked at how popular IPR proceedings at the PTAB have proven. As the USPTO mulls over changes and the Federal Circuit braces itself for a deluge of appeals, Michael Loney reports on how the PTAB is likely to evolve
Patent Trial and Appeal Board proceedings are increasingly popular among pharma firms, in particular among generics eager to find a new way to invalidate big pharma’s patents. Marion Webb reports
Patent owners have discovered that PTAB proceedings are an intense ordeal that leaves little chance for discovery or amending claims, while lawyers more used to district courts have endured a steep learning curve. Michael Loney reports on lessons learned from the PTAB frontlines
The working requirement in the Indian Patents Act is one of several provisions unique to the jurisdiction that raise concerns about patent holders. Mohan Dewan explains the reasoning behind the requirement and how to navigate its intricacies
Legislators and courts all over the world are grappling with the challenge that new technology poses to copyright norms. James Nurton summarises the latest developments and examines why some feel reform is vital
Geert Glas and Nieke Vanavermaete explain how retailers can protect their store layouts with trade marks
A recent rule change in Italy enables patents to be modified at any stage during litigation. Licia Garotti explains why it has been criticised, and sets out some strategies for patent owners
What happens when brands fail to secure the right music licences for their campaigns?
A monthly column devoted to IP curiosities and controversies, named in honour of John of Utynam
May / June 2019
From trademarks to trade secrets: in-house tips on brand protection in China
Despite the well-known struggles in protecting trademarks and trade secrets in China, there are some tried-and-tested strategies to employ, as Karry Lai and Ellie Mertens hear from in-house counsel at a range of domestic and international companies
The material on this site is for financial institutions, professional investors
and their professional advisers. It is for information only. Please read our
Terms and Conditions
before using the site. All material subject to strictly enforced copyright laws.
© 2019 Euromoney Institutional Investor PLC. For help please
see our FAQ.
Switching to MIP International